Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer

• Pashtoon Murtaza Kasi,
• Sakti Chakrabarti,
• Leslie Bucheit,
• Jason Scott Starr,
• Racquel Innis-Shelton,
• Ardaman Shergill,
• Hiba Dada,
• Regina Resta,
• Stephanie Wagner,
• Naomi Fei

Affiliations

Pashtoon Murtaza Kasi

Department of Oncology/Hematology, Division of Internal Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, New York, USA

Sakti Chakrabarti

Medical College of Wisconsin, Milwaukee, Wisconsin, USA

Leslie Bucheit

Guardant Health Inc, Redwood City, California, USA

Jason Scott Starr

Department of Hematology/Oncology, Mayo Clinic Florida, Jacksonville, Florida, USA

Racquel Innis-Shelton

University of Alabama, Birmingham, Alabama, USA

Ardaman Shergill

University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA

Hiba Dada

Guardant Health Inc, Redwood City, California, USA

Regina Resta

New York Oncology Hematology PC, Albany, New York, USA

Stephanie Wagner

Columbus Regional Health Care Center, Columbus, Indiana, USA

Naomi Fei

The University of Iowa Healthcare, Iowa City, Iowa, USA